Menu

Blog

Dec 11, 2023

Breakthrough in pancreatic cancer treatment: Inhibiting specific enzymes slows tumor progression

Posted by in categories: biotech/medical, innovation

Study demonstrates that inhibiting stromal class I histone deacetylases (HDACs) can effectively slow down pancreatic cancer progression, shedding light on a new therapeutic approach targeting the tumor microenvironment.

Leave a reply